JB Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 506943 | NSE: JBCHEPHARM | Pharmaceuticals & Drugs | Small Cap

JB Chem & Pharma Share Price

1,892.70 -12.05 -0.63%
as on 13-Feb'26 16:59

DeciZen - make an informed investing decision on JB Chem & Pharma

Based on:

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Semi Strong

JB Chemicals & Pharmaceuticals stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
41.77
Market Cap:
30,383.1 Cr.
52-wk low:
1,303
52-wk high:
1,939.3

Is JB Chemicals & Pharmaceuticals Ltd an attractive stock to invest in?

1. Is JB Chemicals & Pharmaceuticals Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that JB Chemicals & Pharmaceuticals Ltd is a good quality company.

2. Is JB Chemicals & Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of JB Chemicals & Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is JB Chemicals & Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of JB Chemicals & Pharmaceuticals Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of JB Chem & Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
JB Chemicals & Pharmaceuticals Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 19.1%15.7%12.5%18.3%23%36.3%24%22%25.1%26.8%-
Value Creation
Index
0.40.1-0.10.30.61.70.80.61.21.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 1,1651,1991,2551,5011,6411,8922,1902,8843,2993,7233,955
Sales YoY Gr.-2.9%4.7%19.6%9.3%15.3%15.7%31.7%14.4%12.9%-
Adj EPS 8.88.76.410.716.725.921.725.534.240.645.3
YoY Gr.--1.6%-26.4%68.5%55.6%55.3%-16.4%17.4%34.3%18.7%-
BVPS (₹) 72.181.88792.593.5116.9132.1150177206.1243.1
Adj Net
Profit
149147106172258401335394531632727
Cash Flow from Ops. 171178116193272335147629789884-
Debt/CF from Ops. 10.30.30.10.10.10.20.80.40-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 13.8%17.8%19.4%12.9%
Adj EPS 18.5%19.5%23.3%18.7%
BVPS12.4%17.1%16%16.5%
Share Price 31.4% 25% 24.6% 13.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
13.311.37.511.717.624.617.117.319.920.220.2
Op. Profit
Mgn %
19.61915.919.522.629.223.223.426.627.327.6
Net Profit
Mgn %
12.812.38.511.515.721.215.313.716.11718.4
Debt to
Equity
0.10000000.20.10-
Working Cap
Days
21427629026922419122020320020997
Cash Conv.
Cycle
9596988781758473656169

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 20.20%

Sales growth is growing at healthy rate in last 3 years 19.35%

Net Profit is growing at healthy rate in last 3 years 23.26%

Sales growth is not so good in last 4 quarters at 9.02%

Latest Financials - JB Chemicals & Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 45.3 47
TTM Sales (₹ Cr.) 3,955 4,193
BVPS (₹.) 243.1 249.4
Reserves (₹ Cr.) 3,887 3,988
P/BV 7.79 7.59
PE 41.77 40.31
From the Market
52 Week Low / High (₹) 1303.00 / 1939.30
All Time Low / High (₹) 2.70 / 2029.00
Market Cap (₹ Cr.) 30,383
Equity (₹ Cr.) 16.1
Face Value (₹) 1
Industry PE 41.1

Management X-Ray of JB Chem & Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of JB Chem & Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of JB Chem & Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales1,1651,1991,2551,5011,6411,8922,1902,8843,2993,723
Operating Expenses 9399801,0731,2131,2721,3401,6812,2192,4222,708
Manufacturing Costs175178189203191197248292308351
Material Costs4704694845365696267441,0371,1091,252
Employee Cost 166188217258294306399500565647
Other Costs 129145182215219211290391439458
Operating Profit 2262191822883685525096658771,015
Operating Profit Margin (%) 19.4%18.2%14.5%19.2%22.4%29.2%23.2%23.0%26.6%27.3%
Other Income 56505640501163993737
Interest 1053537534419
Depreciation 40465655656771112135166
Exceptional Items 0000-1000000
Profit Before Tax 231217179269340594471527738877
Tax 5144518771147110138195225
Profit After Tax 179173128182268447361389543653
PAT Margin (%) 15.4%14.4%10.2%12.1%16.3%23.6%16.5%13.5%16.5%17.5%
Adjusted EPS (₹)10.610.27.711.417.428.923.425.135.041.9
Dividend Payout Ratio (%)24%5%13%22%32%29%35%35%35%37%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 1,2231,3881,4531,4851,4451,8062,0412,3212,7463,209
Share Capital 17171716151515151616
Reserves 1,2061,3711,4371,4691,4301,7912,0262,3052,7313,194
Minority Interest0000000000
Debt174492826292626390240
Long Term Debt0000000383240
Short Term Debt174492826292626700
Trade Payables6979100111152164196222332385
Others Liabilities 5395816467053855427351,0831,4951,345
Total Liabilities 2,0052,0972,2282,3272,0122,5392,9994,0154,5974,938

Fixed Assets

Gross Block6809649801,0121,1051,1081,7972,5222,7492,868
Accumulated Depreciation310355410460522544593701824984
Net Fixed Assets 3696095705525835651,2041,8221,9251,883
CWIP 13541715162619557662
Investments 612544567589536811146339531488
Inventories133160176208232279350387461472
Trade Receivables266265301300344374518524625768
Cash Equivalents 1171521122640566491
Others Assets 4795085836412894587238339151,175
Total Assets 2,0052,0972,2282,3272,0122,5392,9994,0154,5974,938

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 171178116193272335147629789884
PBT 231217179269340594471527738877
Adjustment -1010152715-5697203187194
Changes in Working Capital 1-0-40-424-61-294-13-96
Tax Paid -51-49-38-61-87-140-127-89-128-193
Cash Flow From Investing Activity -52-42-24-2824-2314-956-412-290
Capex -189-153-29-41-691-697-757-257-110
Net Investments 11710931091-233700-186-15075
Others 19213211-13-6-255
Cash Flow From Financing Activity -97-165-59-156-305-87-138343-374-574
Net Proceeds from Shares 000000082024
Net Proceeds from Borrowing -0000000521-1790
Interest Paid -2-3-3-4-2-6-2-31-41-7
Dividend Paid -188-6-10-21-141-73-128-128-157-237
Others 92-156-46-131-163-7-8-28-17-354
Net Cash Flow 22-30329-10181316320

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)16.0113.259.0112.3918.327.518.7717.8321.4521.91
ROCE (%)19.1315.6512.518.322.9636.3324.0422.0225.1326.83
Asset Turnover Ratio0.670.580.580.660.760.830.810.850.790.81
PAT to CFO Conversion(x)0.961.030.911.061.010.750.411.621.451.35
Working Capital Days
Receivable Days81818273726973646166
Inventory Days41454947494951454544
Payable Days515768728492887491104

JB Chemicals & Pharmaceuticals Ltd Stock News

JB Chemicals & Pharmaceuticals Ltd FAQs

The current trading price of JB Chem & Pharma on 13-Feb-2026 16:59 is ₹1,892.7.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 12-Feb-2026 the market cap of JB Chem & Pharma stood at ₹30,383.1.
The latest P/E ratio of JB Chem & Pharma as of 12-Feb-2026 is 41.77.
The latest P/B ratio of JB Chem & Pharma as of 12-Feb-2026 is 7.79.
The 52-week high of JB Chem & Pharma is ₹1,939.3 and the 52-week low is ₹1,303.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of JB Chem & Pharma is ₹3,955 ( Cr.) .

About JB Chemicals & Pharmaceuticals Ltd

J.B. Chemicals & Pharmaceuticals, established in 1976, is one of the fastest-growing pharmaceutical companies in India and a leading player in the hypertension and the heart-failure segment. Besides its strong India presence, which accounts for majority of its revenue, its other two home markets are Russia and South Africa. The company exports its finished formulations to many countries. Besides supplying branded generic formulations to several countries, it is also a leader in the manufacturing of medicated lozenges. It has several state-of-the-art manufacturing facilities in India including a dedicated manufacturing facility for lozenges. The manufacturing facilities are certified by leading regulators across the world.

The company has a leading global position in the contract development and manufacturing (CDMO) of medicated lozenges driven by marquee client relationships. The CDMO business provides a great opportunity for growth. The organisation is currently ranked among the top 5 manufacturers of lozenges globally and boasts of some big consumer health/ FMCG companies.

JB Pharma is one of the few Indian companies to successfully implement Osmotic Release Technology for some of its medicines. This technology is an advanced controlled-release oral drug delivery system in the form of a rigid tablet with a semi-permeable outer membrane and a small, laser-drilled hole in it. It is built for a sustained release of the drug over 24 hours.

Business area of the company

J. B. Chemicals & Pharmaceuticals is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and Active Pharmaceutical Ingredients (APIs). 

The company’s core therapies

Cardiology: The company emphasis on heart failure, hypertension and lipid management therapies continue to be a significant contributor in shaping the cardiology market in India 

Nephrology: JB’s commitment to nephro-protection includes public awareness initiatives, accurate diagnostic tests like micral tests and novel molecules for treatment.

Paediatrics: JB’s child health range of products offers effective yet gentle solutions for aiding digestion and sleep, fortifying nutrition to combatting infections and soothing diaper rashes.

Respiratory: JB’s commitment to lung health spans across treatments for allergies, asthma, COPD, lower respiratory tract & viral infections and interstitial lung disease.

Gastroenterology: JB is a pioneer in gastroenterology and has a diverse and comprehensive portfolio, which includes proton-pump inhibitors, pro-kinetics, antacids, laxatives and probiotics in various dosage forms.

Gynaecology: JB plays a vital role in reproductive health with a wide range of treatments for infertility, anaemia, hormonal balance and pregnancy care. Through its quality hormones (IVF), it partner with millions of couples in their journey towards a fuller life.

Dental: The company’s comprehensive treatments for ulcers, pain and infections ensure good oral health and happy expressions.

Wound Care: JB's wound care portfolio offers products for treating both acute wounds with urgency and chronic wounds with patience.

Ophthalmology: The company’s newest ophthalmology portfolio offers anti-infectives, antiglaucoma, NSAIDs and tear substitute drugs.

Milestones 

  • 1976: 1st brick in the foundation laid by late J.B. Mody by incorporating JB Chemicals & Pharmaceuticals Laboratories (JBCPL).
  • 1977: Introduced the product Metrogyl, that went on to become the ‘gold standard’ in the industry.
  • 1980: Forayed into the cardiac segment with the revolutionary product Nicardia.
  • 1985: Got publicly listed and expanded from API to Formulations.
  • 1989: Iconic product Rantac introduced.
  • 2000: Capitalized on the vast Russia & CIS OT market with 2 Brands: Doktor Mom & Rinza.
  • 2003: Received first FDA approval for our Panoli Plant:T10.
  • 2007: Launched the product Cilacar that went on to become a leading brand in cardiology and nephrology.
  • 2008: Made a strategic investment in a company in South Africa called Biotech Laboratories.
  • 2016: Received a silver award from the United States Pharmacopeia (USP) for participation in the Monograph Development & Upgradation Program and preparation and distribution of USP reference substance.
  • 2020: Leading private equity firm Kohlberg Kravis Roberts & Co. Inc. (KKR), acquired a controlling stake of JBCPL.
  • 2021: Ranked 28th in the Industry (ORG- IMS) with 5 brands: Rantac (Anti – Peptic Ulcer ant), Metrogyl (Amebicides), Nicardia ( Calcium Channel Blocker) and Cilacar-T featuring in top 300 brands of the Indian pharmaceutical market.
  • 2022: Acquisition of Azmarda and Sanzyme.
  • 2022: Launch of New JB identity.
  • 2023: 6 brands in top 300 IPM brands as per IQVIA.
  • 2023: Fastest growing company among the top 10 players in the cardiology segment.
  • 2024-25: Five of JB Pharma’s flagship brands now feature among the top 150 brands in the Indian Pharmaceutical Market (IPM). 
  • 2024-25: Sporlac has made its way into the top 300 brands, marking a significant milestone in its growth journey.
  • 2024-25: Torrent Pharmaceuticals has entered into definitive agreements to acquire a controlling stake in JB Pharma from KKR.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×